-transparent.png){kind=logo}
Episodic secretion of LH, and the responses of serum LH, alpha-subunit, and testosterone concentrations to the acute administration of LHRH and the chronic administration of the LHRH agonist analog [D-Trp6-Pro9-NEt]LHRH (D-Trp6-Pro9) were evaluated in a 33-yr-old man previously reported to have an LH-secreting pituitary tumor unaccompanied by FSH hypersecretion. Basal serum LH and alpha-subunit concentrations were elevated [57 +/- 0.7 (SEM) mIU/ml (range, 45-71) and 26 ng/ml, respectively]. Frequent sampling revealed six LH secretory spikes over a 24-h period with increments above basal levels varying from 23-40% and interspike intervals ranging from 1.5-5 h. The concentrations of LH or alpha-subunit after iv administration of 150 micrograms LHRH did not increase above these intrinsic LH secretory increments (delta LH: 23%; delta alpha-subunit: 21%). The low basal serum FSH concentrations (3.5 mIU/ml) and elevated basal serum testosterone levels (1480 ng/dl) were unchanged after LHRH. Administration of clomiphene citrate produced no increase in serum LH, FSH, or testosterone concentrations. An attempt was made to decrease LH secretion in this patient using D-Trp6-Pro9. Administration of 200 micrograms daily sc of this LHRH analog for 21 days was associated with increases in serum LH and alpha-subunit concentrations. Mean serum LH and alpha-subunit levels for the 21 days of analog administration were 110 +/- 5.4 (SEM) mIU/ml (range, 70-170) and 64 +/- 3 (SEM) ng/ml (range, 32-84), respectively. During the 9-day period after discontinuance of the LHRH analog, levels of both serum LH and alpha-subunit declined precipitously and mean serum LH and alpha-subunit levels were 58 +/- 7 (SEM) mIU/ml (range, 18-90) and 22 +/- 3 (SEM) ng/ml (range, 12-44), respectively. We conclude that this patient's pituitary tumor has diminished responsiveness to acute LHRH administration and that the effect of chronic D-Trp6-Pro9 is stimulatory rather than inhibitory, as occurs after chronic administration of this analog to normal subjects. The blunted responsiveness to LHRH administration and the lack of response to clomiphene citrate suggest tumor autonomy. The presence of modest paradoxical responsiveness of serum LH and alpha-subunit concentrations during the course of daily D-Trp6-Pro9 administration suggests that central regulatory mechanisms, if present, are abnormal.
S H Roman, and
M Goldstein, and
I A Kourides, and
F Comite, and
C W Bardin, and
D T Krieger
February 1983,
Contraception,
S H Roman, and
M Goldstein, and
I A Kourides, and
F Comite, and
C W Bardin, and
D T Krieger
June 1984,
Biology of reproduction,
S H Roman, and
M Goldstein, and
I A Kourides, and
F Comite, and
C W Bardin, and
D T Krieger
February 1984,
Steroids,
S H Roman, and
M Goldstein, and
I A Kourides, and
F Comite, and
C W Bardin, and
D T Krieger
June 1985,
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
S H Roman, and
M Goldstein, and
I A Kourides, and
F Comite, and
C W Bardin, and
D T Krieger
February 1987,
Endocrinology,
S H Roman, and
M Goldstein, and
I A Kourides, and
F Comite, and
C W Bardin, and
D T Krieger
June 1988,
Molecular endocrinology (Baltimore, Md.),
S H Roman, and
M Goldstein, and
I A Kourides, and
F Comite, and
C W Bardin, and
D T Krieger
November 1979,
Endocrinology,
S H Roman, and
M Goldstein, and
I A Kourides, and
F Comite, and
C W Bardin, and
D T Krieger
December 1978,
Endocrinology,
S H Roman, and
M Goldstein, and
I A Kourides, and
F Comite, and
C W Bardin, and
D T Krieger
November 1997,
Domestic animal endocrinology,
S H Roman, and
M Goldstein, and
I A Kourides, and
F Comite, and
C W Bardin, and
D T Krieger
January 1980,
International journal of fertility,
